The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study (Q48901514)

16 February 2018

http://europepmc.org/abstract/MED/24375059

title

The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study (English)

1 reference

16 February 2018

http://europepmc.org/abstract/MED/24375059

1 reference

1 reference

1 reference

peritoneal carcinomatosis

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

D Hompes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A D'Hoore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

A Wolthuis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

S Fieuws

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

B Mirck

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

S Bruin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

28 December 2013

1 reference

16 February 2018

http://europepmc.org/abstract/MED/24375059

published in

Journal of Surgical Oncology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

527-532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

12 June 2020

cites work

1 reference

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

21 January 2018

1 reference

Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study

21 January 2018

1 reference

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

21 January 2018

1 reference

Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.

21 January 2018

1 reference

A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer

21 January 2018

1 reference

Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma

21 January 2018

1 reference

Treatment and prevention of peritoneal carcinomatosis from colorectal cancer

21 January 2018

1 reference

Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies

21 January 2018

1 reference

Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.

21 January 2018

1 reference

Pharmacokinetics of intraperitoneal mitomycin C

21 January 2018

1 reference

Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution

21 January 2018

1 reference

Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

21 January 2018

1 reference

Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis

21 January 2018

1 reference

Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends.

21 January 2018

1 reference

Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy

21 January 2018

1 reference

Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy

21 January 2018

1 reference

A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.

21 January 2018

1 reference

Oxaliplatin-safety profile: neurotoxicity

21 January 2018

1 reference

Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C.

21 January 2018

1 reference

Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C.

21 January 2018

1 reference

Is Platinum Present in Blood and Urine from Treatment Givers during Hyperthermic Intraperitoneal Chemotherapy?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.23546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24375059%20AND%20SRC:MED&resulttype=core&format=json